1. Home
  2. NIU vs AVXL Comparison

NIU vs AVXL Comparison

Compare NIU & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Niu Technologies

NIU

Niu Technologies

N/A

Current Price

$1.95

Market Cap

200.8M

ML Signal

N/A

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

N/A

Current Price

$2.86

Market Cap

237.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NIU
AVXL
Founded
2014
2004
Country
China
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
200.8M
237.2M
IPO Year
2018
2013

Fundamental Metrics

Financial Performance
Metric
NIU
AVXL
Price
$1.95
$2.86
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$3.50
$22.00
AVG Volume (30 Days)
155.3K
717.7K
Earning Date
05-18-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$25.54
N/A
Revenue Next Year
$17.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.90
$2.26
52 Week High
$5.67
$10.38

Technical Indicators

Market Signals
Indicator
NIU
AVXL
Relative Strength Index (RSI) 36.52 45.64
Support Level $1.90 $2.62
Resistance Level $2.04 $3.63
Average True Range (ATR) 0.06 0.18
MACD 0.01 -0.06
Stochastic Oscillator 21.43 12.97

Price Performance

Historical Comparison
NIU
AVXL

About NIU Niu Technologies

Niu Technologies designs, manufactures, and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycles, mopeds, and bicycle series, including the NQi, MQi, UQi, FQi series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: